Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.
side-effect profile and so on before confirming the lessons learned with only compounds deemed to have good chances of success in Phase III trials is not a new paradigm in drug development ...
BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.
Pharmaceutical Technology on MSN2d
Vivace closes $35m in Series D for cancer drug developmentVivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...
The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...
Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...
After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the ...
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback